These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 191016)

  • 1. Fibroblast phosphodiesterase deficiency in Niemann-Pick disease.
    Fensom AH; Benson PF; Babarik AW; Grant AR; Jacobs L
    Biochem Biophys Res Commun; 1977 Feb; 74(3):877-83. PubMed ID: 191016
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited neuropathies related to disorders of lipid metabolism.
    Thomas PK
    Adv Neurol; 1988; 48():133-44. PubMed ID: 2446477
    [No Abstract]   [Full Text] [Related]  

  • 3. Sphingomyelinase defect in Niemann-Pick disease, type C, fibroblasts.
    Besley GT
    FEBS Lett; 1977 Aug; 80(1):71-4. PubMed ID: 19295
    [No Abstract]   [Full Text] [Related]  

  • 4. A profound deficiency of (CH3-14C)choline sphingomyelin-cleaving enzyme in Niemann-Pick disease type B.
    Orii T; Nakamura F; Kudoh T; Tsuchihashi K; Nakao T
    Tohoku J Exp Med; 1975 Oct; 117(2):193-5. PubMed ID: 174246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on pyrophosphate diesterase activity in cultured human fibroblasts: a deficiency in Niemann-Pick disease.
    Besley GT; Moss SE
    Clin Chim Acta; 1981 Nov; 117(1):75-84. PubMed ID: 6277531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingomyelinases and the genetic defects in Niemann-Pick disease.
    Callahan JW; Khalil M
    Adv Exp Med Biol; 1976; 68():367-78. PubMed ID: 7108
    [No Abstract]   [Full Text] [Related]  

  • 7. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic diagnosis of sphingolipidoses.
    Suzuki K
    Methods Enzymol; 1987; 138():727-62. PubMed ID: 2885713
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic Niemann-Pick disease with sphingomyelinase deficiency in two brothers with mental retardation.
    Sogawa H; Horino K; Nakamura F; Kudoh T; Oyanagi K; Yamanouchi T; Minami R; Nakao T; Watanabe A; Matsuura Y
    Eur J Pediatr; 1978 Jul; 128(4):235-40. PubMed ID: 208852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingomyelinase in cultured skin fibroblasts from normal and Niemann-Pick type C patients.
    Poulos A; Hudson N; Ranieri E
    Clin Genet; 1983 Oct; 24(4):225-33. PubMed ID: 6315279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activators for sphingohydrolases and the nature of the sphingomyelinase deficiency in Niemann-Pick disease types A, B and C (author's transl)].
    Baraton G; Revol A
    Clin Chim Acta; 1977 May; 76(3):339-43. PubMed ID: 192496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatofocusing of skin fibroblast sphingomyelinase: alterations in Niemann-Pick disease type C shared by GM1-gangliosidosis.
    Vanier MT; Rousson R; Louisot P
    Clin Chim Acta; 1983 May; 130(2):155-61. PubMed ID: 6307547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic abnormalities in diseases of sphingolipid metabolism.
    Brady RO
    Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific enzymatic diagnosis and ultrastructural analysis of peripheral leukocytes in infantile form of Niemann-Pick sphingomyelinosis.
    László A; Klujber L; Streitmann K; Barb E
    Acta Paediatr Hung; 1990; 30(1):99-105. PubMed ID: 2156543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal storage diseases.
    Glew RH; Basu A; Prence EM; Remaley AT
    Lab Invest; 1985 Sep; 53(3):250-69. PubMed ID: 2993742
    [No Abstract]   [Full Text] [Related]  

  • 16. Basic findings and current developments in sphingolipidoses.
    Pilz H; Heipertz R; Seidel D
    Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of fluorescent lipid substrates for the study of hereditary lysosomal lipidoses. Application to the diagnosis of Niemann-Pick disease].
    Douste-Blazy L; Levade T; Salvayre R; Gatt S
    Bull Acad Natl Med; 1988 Jun; 172(6):807-13. PubMed ID: 2847857
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dimethylsulfoxide on sphingomyelinase in cultured human fibroblasts and correction of sphingomyelinase deficiency in fibroblasts from Niemann-Pick patients.
    Sakuragawa N; Sato M; Yoshida Y; Kamo I; Arima M; Satoyoshi E
    Biochem Biophys Res Commun; 1985 Jan; 126(2):756-62. PubMed ID: 2983689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An animal model of human acid sphingomyelinase deficiency (Niemann-Pick disease) and the study of its enzyme replacement (the Japan Society of Human Genetics award lecture).
    Kitagawa T
    Jinrui Idengaku Zasshi; 1987 Jun; 32(2):55-69. PubMed ID: 2830422
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of acid sphingomyelinase in the mitochondria-lysosome fraction of brain from Niemann-Pick mice.
    Tsuda M; Owada M; Kitagawa T; Miyawaki S
    J Inherit Metab Dis; 1985; 8(3):147-8. PubMed ID: 3027450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.